Procept Biorobotics Corp
PRCT34.260USD
+2.200+6.86%
收盘 12/22, 16:00（美东）报价延迟15分钟
1.91B总市值
亏损市盈率 TTM
关于 Procept Biorobotics Corp 公司
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
Procept Biorobotics Corp简介
公司代码PRCT
公司名称Procept Biorobotics Corp
上市日期Sep 15, 2021
CEOWood (Larry L)
员工数量756
证券类型Ordinary Share
年结日Sep 15
公司地址150 Baytech Drive
城市SAN JOSE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编95134
电话16502329832
网址https://www.procept-biorobotics.com/
公司代码PRCT
上市日期Sep 15, 2021
CEOWood (Larry L)
Procept Biorobotics Corp公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
863.16K
+2.37%
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
188.36K
+3056.17%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
134.25K
+1.16%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
66.61K
-6.22%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
14.38K
+11.97%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Thomas M. Prescott
Thomas M. Prescott
Independent Chairman of the Board
Independent Chairman of the Board
3.90K
+65.22%
Ms. Alaleh Azarkhish Nouri
Ms. Alaleh Azarkhish Nouri
Executive Vice President, Chief Legal Officer, Corporate Secretary
Executive Vice President, Chief Legal Officer, Corporate Secretary
--
--
Ms. Amy M. Dodrill
Ms. Amy M. Dodrill
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
863.16K
+2.37%
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
188.36K
+3056.17%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
134.25K
+1.16%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
66.61K
-6.22%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
14.38K
+11.97%
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Hand pieces and other consumables
49.13M
62.05%
System sales and rentals
25.03M
31.61%
Service
5.02M
6.34%
地区USD
名称
营收
占比
United States
69.58M
87.88%
Outside United States
9.60M
12.12%
业务
地区
业务USD
名称
营收
占比
Hand pieces and other consumables
49.13M
62.05%
System sales and rentals
25.03M
31.61%
Service
5.02M
6.34%
股东统计
更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
14.12%
The Vanguard Group, Inc.
9.29%
BlackRock Institutional Trust Company, N.A.
6.67%
AllianceBernstein L.P.
6.12%
T. Rowe Price Investment Management, Inc.
3.67%
其他
60.13%
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
14.12%
The Vanguard Group, Inc.
9.29%
BlackRock Institutional Trust Company, N.A.
6.67%
AllianceBernstein L.P.
6.12%
T. Rowe Price Investment Management, Inc.
3.67%
其他
60.13%
股东类型
持股股东
占比
Investment Advisor
63.63%
Investment Advisor/Hedge Fund
32.62%
Individual Investor
4.43%
Research Firm
3.93%
Hedge Fund
2.68%
Bank and Trust
2.31%
Pension Fund
0.76%
Venture Capital
0.66%
Family Office
0.08%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
536
55.75M
99.78%
-1.67M
2025Q2
535
55.45M
100.20%
-990.27K
2025Q1
539
53.99M
97.68%
-2.82M
2024Q4
499
53.70M
99.42%
+875.53K
2024Q3
449
49.13M
94.16%
-1.41M
2024Q2
393
47.17M
91.61%
-2.29M
2024Q1
345
48.36M
95.04%
-4.45M
2023Q4
326
47.80M
94.81%
-4.63M
2023Q3
322
46.77M
93.30%
+2.15M
2023Q2
298
38.23M
84.44%
-1.74M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Fidelity Management & Research Company LLC
7.70M
13.85%
-416.21K
-5.13%
Jun 30, 2025
The Vanguard Group, Inc.
5.24M
9.41%
+120.94K
+2.36%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.73M
6.7%
+279.11K
+8.09%
Jun 30, 2025
AllianceBernstein L.P.
2.16M
3.88%
+13.16K
+0.61%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
1.53M
2.75%
+112.42K
+7.94%
Jun 30, 2025
Westfield Capital Management Company, L.P.
1.60M
2.87%
+849.79K
+113.52%
Jun 30, 2025
Mackenzie Investments
708.66K
1.27%
+708.66K
--
Jun 30, 2025
Champlain Investment Partners, LLC
1.07M
1.92%
+394.45K
+58.33%
Jun 30, 2025
Artisan Partners Limited Partnership
986.25K
1.77%
+46.80K
+4.98%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Global X HealthTech ETF
1.64%
State Street SPDR S&P Health Care Equipment ETF
1.62%
ALPS Disruptive Technologies ETF
0.86%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.7%
Global X Robotics & Artificial Intelligence ETF
0.7%
Main Thematic Innovation ETF
0.46%
Harbor Health Care ETF
0.35%
Langar Global HealthTech ETF
0.32%
iShares U.S. Medical Devices ETF
0.22%
Nuveen ESG Small-Cap ETF
0.17%
查看更多
Global X HealthTech ETF
占比1.64%
State Street SPDR S&P Health Care Equipment ETF
占比1.62%
ALPS Disruptive Technologies ETF
占比0.86%
First Trust Nasdaq Lux Digi Health Solutions ETF
占比0.7%
Global X Robotics & Artificial Intelligence ETF
占比0.7%
Main Thematic Innovation ETF
占比0.46%
Harbor Health Care ETF
占比0.35%
Langar Global HealthTech ETF
占比0.32%
iShares U.S. Medical Devices ETF
占比0.22%
Nuveen ESG Small-Cap ETF
占比0.17%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Procept Biorobotics Corp的前五大股东是谁？
Procept Biorobotics Corp 的前五大股东如下：
Fidelity Management & Research Company LLC持有股份：7.70M，占总股份比例：13.85%。
The Vanguard Group, Inc.持有股份：5.24M，占总股份比例：9.41%。
BlackRock Institutional Trust Company, N.A.持有股份：3.73M，占总股份比例：6.70%。
AllianceBernstein L.P.持有股份：2.16M，占总股份比例：3.88%。
T. Rowe Price Investment Management, Inc.持有股份：1.53M，占总股份比例：2.75%。
Fidelity Management & Research Company LLC持有股份：7.70M，占总股份比例：13.85%。
The Vanguard Group, Inc.持有股份：5.24M，占总股份比例：9.41%。
BlackRock Institutional Trust Company, N.A.持有股份：3.73M，占总股份比例：6.70%。
AllianceBernstein L.P.持有股份：2.16M，占总股份比例：3.88%。
T. Rowe Price Investment Management, Inc.持有股份：1.53M，占总股份比例：2.75%。
Procept Biorobotics Corp的前三大股东类型是什么？
Procept Biorobotics Corp 的前三大股东类型分别是：
Fidelity Management & Research Company LLC
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Fidelity Management & Research Company LLC
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
有多少机构持有Procept Biorobotics Corp(PRCT)的股份？
截至2025Q3，共有536家机构持有Procept Biorobotics Corp的股份，合计持有的股份价值约为55.75M，占公司总股份的99.78%。与2025Q2相比，机构持股有所增加，增幅为-0.42%。
哪个业务部门对Procept Biorobotics Corp的收入贡献最大？
在FY2025Q2，Hand pieces and other consumables业务部门对Procept Biorobotics Corp的收入贡献最大，创收49.13M，占总收入的62.05%。
